Results 41 to 50 of about 22,586,581 (189)

Post-CAR-T cell therapy presenting as proteinaceous lymphadenopathy

open access: yesHuman Pathology: Case Reports, 2021
Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma and is often treated with chemotherapy, autologous stem cell transplant, and chimeric antigen receptor (CAR-T) cell therapy.
Mishi Bhushan, Kirthi R. Kumar
doaj   +1 more source

Diffuse Large B-Cell Lymphoma of the Prostate [PDF]

open access: yesArchives of Pathology and Laboratory Medicine, 2014
In this article, we review prostatic lymphomas and discuss the differential diagnosis of high-grade malignant neoplasms of the prostate. We illustrate this with a case of a 46-year-old man seen with lower urinary tract obstruction who had diffuse involvement by a high-grade malignancy on prostate biopsy.
Joshua I, Warrick   +2 more
openaire   +2 more sources

Overexpression of FoxM1 offers a promising therapeutic target in diffuse large B-cell lymphoma

open access: yesHaematologica, 2012
Background FoxM1 has been shown to play a critical role in the pathogenesis of various epithelial malignancies. However, its role in lymphoid malignancies has not been fully clarified.
Shahab Uddin   +6 more
doaj   +1 more source

Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma

open access: yes, 2016
An association between Epstein-Barr Virus (EBV) infection and lymphoproliferative diseases has been reported with EBV + diffuse large B cell-lymphoma (DLBCL) of the elderly described as a distinct entity.
Hohaus, Stefan   +13 more
core   +1 more source

Case of Gastric Diffuse Large B-Cell Lymphoma

open access: yesCase Reports in Oncology, 2019
The gastrointestinal (GI) tract is the predominant site of extra nodal lymphoma involvement. In the United States (US), gastric lymphoma is the most common extra nodal site of lymphoma.
Usman A. Pirzada   +4 more
doaj   +1 more source

Retrospective Analysis of Pemetrexed-based Chemotherapy Regimens on Mid-elderly Non-Hodgkin's Lymphoma

open access: yesZhongliu Fangzhi Yanjiu, 2020
Objective To analyze the safety and efficacy of pemetrexed-based chemotherapy on patients with mid-elderly non-Hodgkin's lymphoma. Methods We retrospectively reviewed the clinical data of patients with non-Hodgkin's lymphoma treated with pemetrexed-based
WEN Tingyu   +6 more
doaj   +1 more source

Non-Hodgkin’s Lymphoma in Buccal Vestibule -Case Report [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2014
Lymphomas are malignant neoplasms arising from lymphocytes B cell or T cell that affects mainly lymph nodes, spleen and other non hematopoietic tissues. They are classified as Hodgkin’s lymphoma (HL) and non-Hodgkin’s lymphoma (NHL). Diffuse large B-cell
Indira Reddy   +4 more
doaj   +1 more source

Identification and characterization of peripheral T-cell lymphoma-associated SEREX antigens. [PDF]

open access: yes, 2011
Peripheral T-cell lymphomas (PTCL) are generally less common and pursue a more aggressive clinical course than B-cell lymphomas, with the T-cell phenotype itself being a poor prognostic factor in adult non-Hodgkin lymphoma (NHL).
Graham P. Collins   +34 more
core   +2 more sources

Primary thyroid lymphoma: A rare disease

open access: yesJournal of Cytology, 2014
Primary thyroid lymphomas are rare neoplasms comprising of 1-5% of thyroid malignancies. These are predominantly B-cell in origin. Here, we report a case of 60 years lady, a known case of lymphocytic thyroiditis, diagnosed as thyroid lymphoma (diffuse ...
Deepti Verma   +3 more
doaj   +1 more source

T-cell/histiocyte-rich large B-cell lymphoma presenting as a primary central nervous system lymphoma

open access: yesRare Tumors, 2015
Primary central nervous system (PCNSL) lymphoma is an aggressive extranodal non-Hodgkin lymphoma, and most cases are classified as diffuse large B-cell lymphoma (DLBCL) by histology.
Pooja Advani   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy